TheraRadar

Pharma Intelligence, Simplified

← Back
Data updated: Mar 10, 2026

COBREK PHARMA

Metabolic
Pharma

COBREK PHARMA is a pharmaceutical company focused on Metabolic. Key products include DOXERCALCIFEROL.

-
Since
1
Drugs
-
Trials
2
Approved (2yr)

Key Drugs

No active drugs

Recent Activity

SEC Filings Pro
Loading...

Therapeutic Focus

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Metabolic 100%
1 drugs

Pipeline Strength Pro

Loading...